Welcome to Labeled Immunoassays and Clinical Medicine website!

The Value of Serum CA724 in Differential Diagnosis of Gastric Cancer and Gastric Benign Diseases Based on a Meta-analysis

Expand
  • Department of Radiation Ontology, Second Affiliated Hospital of Soochow University, Suzhou 215004, China

Received date: 2015-02-04

  Revised date: 2015-05-20

  Online published: 2015-09-16

Abstract

Abstract: Objective To evaluate the differential diagnostic value of serum CA724 on gastric cancer and gastric benign diseases. Methods Chinese medical databases (2011-2014) were searched to collect articles in Chinese which evaluated the diagnostic value of CA724 in patients with gastric cancer. The data were analyzed by using Meta-Disc1.4 software. Meta-analysis of the reported sensitivity and specificity of each study and summary receiver operating characteristic (SROC) curve were performed. Results A total of 9 researches involving 2048 patients were included. The pooled sensitivity and specificity were 42% (39%~45%) and 94% (92%~95%). The area under the SROC curve was 0.8769 (0.7256~1). Conclusion CA724 can be regarded as a valuable marker in the differential diagnosis of gastric cancer and gastric benign diseases.

Cite this article

XING Peng-fei, ZOU Li . The Value of Serum CA724 in Differential Diagnosis of Gastric Cancer and Gastric Benign Diseases Based on a Meta-analysis[J]. Labeled Immunoassays and Clinical Medicine, 2015 , 22(6) : 499 . DOI: 10.11748/bjmy.issn.1006-1703.2015.06.007

Options
Outlines

/